The Keranique Lawsuit has gained significant attention as a legal challenge to the popular women’s hair regrowth brand, accusing the company of deceptive advertising. The lawsuit claims that Keranique misled consumers by advertising its products as “the only FDA-approved topical solution for women’s hair regrowth.” This marketing message is at the heart of the controversy and is now the subject of legal action.
Consumers purchased Keranique products believing they were unique FDA-approved treatments. However, the lawsuit argues this claim is false, as other products with the same active ingredient, minoxidil, are also FDA-approved.
This article examines the key allegations in the Keranique Lawsuit, its legal basis, and what it means for consumers.
What Is the Keranique Lawsuit About?
The Keranique Lawsuit revolves around allegations that the company misrepresented its hair regrowth products as the only FDA-approved topical solution for women, which plaintiffs claim is misleading and false. This claim was prominently displayed on the product packaging, leading many consumers to believe they were purchasing a unique, FDA-approved solution for hair regrowth.
Key Allegations in the Keranique Lawsuit
- False Advertising: Keranique claimed exclusive FDA approval, though multiple competitors sell similar products with the same FDA-approved ingredient, minoxidil 2%.
- Competitive Landscape: Other brands, such as Rogaine, use the same active ingredient (minoxidil) and are FDA-approved, making the exclusivity claim misleading.
- Premium Pricing: Keranique’s premium pricing is largely based on the false claim of FDA exclusivity. Consumers were led to believe they were paying for a unique product.
Legal Basis of the Keranique Lawsuit
The plaintiffs in the Keranique Lawsuit have filed their case under Pitre v. Scientific Hair Research, LLC and accuse the company of violating several consumer protection laws, particularly in California. Below is a breakdown of the key legal claims:
| Legal Claim | Explanation |
| Unfair Competition Law (UCL) | Claims that Keranique’s false FDA approval representation constitutes unfair business practices. |
| California Consumer Legal Remedies Act (CLRA) | Consumers were misled into purchasing based on deceptive advertising. |
| False Advertising Law | Keranique violated false advertising statutes by claiming exclusivity when it does not exist. |
| Economic Harm | Consumers paid higher prices under the false assumption of FDA exclusivity. |
Why Plaintiffs Say Consumers Were Misled
The primary reason behind the Keranique Lawsuit is that consumers were misled by the claim “THE ONLY FDA‑APPROVED…” on Keranique’s packaging. Plaintiffs argue that the use of such a statement misled consumers into thinking the product was the only one approved for women’s hair regrowth, when in fact, many other products on the market are FDA-approved with the same active ingredient.
- False Perception of Exclusivity: The phrase “only FDA-approved” led consumers to believe Keranique had an advantage over other products, prompting them to purchase it at a higher price.
- Availability of Cheaper Alternatives: Consumers failed to realize that other FDA-approved products containing minoxidil 2% are available at a lower cost from major retailers.
- Premium Pricing for No Advantage: The Keranique Lawsuit argues that consumers were charged a premium for a product that did not offer the unique advantages they were led to believe.
Earlier Lawsuits Over Keranique Hair Regrowth Products
In addition to the current Keranique Lawsuit, earlier legal issues have highlighted consumer dissatisfaction with the product’s efficacy. For example, in 2019/2020, a separate case was filed in West Virginia where a plaintiff claimed that using Keranique products resulted in severe hair loss, contrary to the company’s marketing.
This case sheds light on a broader issue of product performance concerns, alongside the current focus on false advertising.
Implications for Consumers & the Hair Regrowth Market
The Keranique Lawsuit has raised concerns about transparency in the health and beauty industries, particularly regarding the marketing of FDA-approved products. Consumers have a right to accurate information when making health-related purchases, and this case could set a precedent for stricter regulations on advertising claims.
Key Takeaways for Consumers:
- Compare Product Claims: Consumers should verify claims of FDA approval and exclusivity before making a purchase.
- Evaluate Multiple Options: There are many hair regrowth solutions available, and the price difference should be considered carefully.
- Understand FDA Approval: Just because an ingredient is FDA-approved doesn’t mean the product has unique regulatory status over others.
Potential Class Action Settlement or Damages
If the Keranique class action Lawsuit progresses to a settlement, consumers who were affected by the misleading advertising can expect potential compensation in the form of:
- Refunds: Consumers who purchased the products based on the false claim may be entitled to refunds.
- Free Products: Some class action settlements offer free products or vouchers for affected consumers.
- Monetary Damages: If the class action is successful, plaintiffs may receive compensation for economic harm or emotional distress caused by the deceptive marketing.
Consumer Reviews and Testimonials
The Keranique Lawsuit also reflects the varied experiences of consumers, some of whom claim the product worked well, while others felt deceived:
- “Keranique helped my hair regrowth and made it thicker. The claim about FDA approval made me feel confident in my purchase,” says one satisfied user.
- “I used Keranique for months with no results. I feel tricked by their advertising and regret paying the premium price,” says a frustrated customer.
These contrasting reviews show that while some people find the product effective, the lawsuit reflects widespread dissatisfaction with the marketing and claims about FDA approval.
Impact on the Industry
The Keranique Lawsuit has the potential to reshape the way beauty and health companies advertise their products. If the lawsuit leads to a judgment against the brand, it could result in:
- Stricter Advertising Regulations: Other companies in the beauty and health industry may face more stringent rules regarding the advertising of FDA-approved products.
- Increased Consumer Awareness: Consumers will likely become more cautious and educated about FDA claims and market exclusivity.
- Corporate Accountability: Companies may adjust their marketing strategies to ensure transparency and avoid misleading claims that could lead to legal action.
Where the Keranique Lawsuit Case Stands
As of early 2026, the Keranique Lawsuit is still in its pre‑trial stage. The complaint seeks class certification on behalf of U.S. consumers who purchased the product under the belief that it was FDA-approved in a unique manner. If the class is certified, it could lead to broader litigation or settlement discussions.
Conclusion
The Keranique Lawsuit underscores the importance of honesty and transparency in health and beauty product advertising. If successful, the lawsuit could lead to compensation for affected consumers and force a reassessment of how companies communicate FDA approval claims. Consumers should remain vigilant when purchasing products, particularly those that make exclusive claims, and be aware of their rights in cases of false advertising.
Keranique Lawsuit FAQs
1. What is the Keranique Lawsuit about?
The Keranique Lawsuit involves allegations that the company falsely advertised its hair regrowth products as the only FDA-approved solution for women’s hair regrowth, misleading consumers.
2. Why are consumers suing in the Keranique Lawsuit?
Consumers in the Keranique Lawsuit claim they were deceived by false advertising, leading them to overpay for a product that they believed had exclusive FDA approval.
3. What are the main allegations in the Keranique Lawsuit?
- False Advertising: The Keranique Lawsuit argues that Keranique misrepresented its products as the only FDA-approved solution.
- Premium Pricing: Consumers paid more due to misleading claims of exclusivity.
4. How does the Keranique Lawsuit impact consumers?
Consumers affected by the Keranique Lawsuit may be eligible for refunds, damages, or free products if the case is successful.
